195 related articles for article (PubMed ID: 17404719)
21. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.
Aziz Z; Siang TC; Badarudin NS
Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):223-8. PubMed ID: 16947117
[TBL] [Abstract][Full Text] [Related]
22. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong.
Lee KK; Chan TY; Raymond K; Critchley JA
Ann Pharmacother; 1994 Dec; 28(12):1400-3. PubMed ID: 7696734
[TBL] [Abstract][Full Text] [Related]
23. Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital.
Goldstein LH; Berlin M; Saliba W; Elias M; Berkovitch M
J Clin Pharmacol; 2013 Nov; 53(11):1220-5. PubMed ID: 23852627
[TBL] [Abstract][Full Text] [Related]
24. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
[TBL] [Abstract][Full Text] [Related]
25. Nurses' attitudes and spontaneous adverse drug reaction reporting: a case-control study in Portugal.
Mendes Marques JI; Polónia JM; Figueiras AG; Costa Santos CM; Herdeiro MT
J Nurs Manag; 2016 Apr; 24(3):409-16. PubMed ID: 26481698
[TBL] [Abstract][Full Text] [Related]
26. Attitudinal survey of voluntary reporting of adverse drug reactions.
Eland IA; Belton KJ; van Grootheest AC; Meiners AP; Rawlins MD; Stricker BH
Br J Clin Pharmacol; 1999 Oct; 48(4):623-7. PubMed ID: 10583035
[TBL] [Abstract][Full Text] [Related]
27. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
[TBL] [Abstract][Full Text] [Related]
28. Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017.
Bukic J; Rusic D; Mas P; Karabatic D; Bozic J; Seselja Perisin A; Leskur D; Krnic D; Tomic S; Modun D
BMC Pharmacol Toxicol; 2019 Oct; 20(1):60. PubMed ID: 31627740
[TBL] [Abstract][Full Text] [Related]
29. Developing an adverse drug reaction reporting system at a teaching hospital.
Baniasadi S; Fahimi F; Shalviri G
Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
[TBL] [Abstract][Full Text] [Related]
30. Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region.
Irujo M; Beitia G; Bes-Rastrollo M; Figueiras A; Hernández-Díaz S; Lasheras B
Drug Saf; 2007; 30(11):1073-82. PubMed ID: 17973543
[TBL] [Abstract][Full Text] [Related]
31. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study.
Johansson ML; Hägg S; Wallerstedt SM
BMC Clin Pharmacol; 2011 Sep; 11():14. PubMed ID: 21899766
[TBL] [Abstract][Full Text] [Related]
32. [Reporting of side-effects--a system in need of improvement. Reporting of a physician questionnaire].
Ekbom Y; Hedenmalm K; Dalin L; Lönnroth K; Persson I
Lakartidningen; 2002 Aug; 99(34):3290-5. PubMed ID: 12362847
[TBL] [Abstract][Full Text] [Related]
33. Reporting adverse drug reactions on a geriatric ward: a pilot project.
Somers A; Petrovic M; Robays H; Bogaert M
Eur J Clin Pharmacol; 2003 Feb; 58(10):707-14. PubMed ID: 12610749
[TBL] [Abstract][Full Text] [Related]
34. Under-reporting of serious adverse drug reactions in Sweden.
Bäckström M; Mjörndal T; Dahlqvist R
Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):483-7. PubMed ID: 15269932
[TBL] [Abstract][Full Text] [Related]
35. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.
Figueiras A; Herdeiro MT; Polónia J; Gestal-Otero JJ
JAMA; 2006 Sep; 296(9):1086-93. PubMed ID: 16954488
[TBL] [Abstract][Full Text] [Related]
36. Knowledge about adverse drug reactions reporting among healthcare professionals in Nepal.
Santosh KC; Tragulpiankit P; Edwards IR; Gorsanan S
Int J Risk Saf Med; 2013 Jan; 25(1):1-16. PubMed ID: 23442293
[TBL] [Abstract][Full Text] [Related]
37. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
[TBL] [Abstract][Full Text] [Related]
38. The adverse drug reaction reporting assignment for specialist oncology nurses: a preliminary evaluation of quality, relevance and educational value in a prospective cohort study.
Schutte T; van Eekeren R; Richir M; van Staveren J; van Puijenbroek E; Tichelaar J; van Agtmael M
Naunyn Schmiedebergs Arch Pharmacol; 2018 Jan; 391(1):17-26. PubMed ID: 29063137
[TBL] [Abstract][Full Text] [Related]
39. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions.
Li Q; Zhang SM; Chen HT; Fang SP; Yu X; Liu D; Shi LY; Zeng FD
Chin Med J (Engl); 2004 Jun; 117(6):856-61. PubMed ID: 15198887
[TBL] [Abstract][Full Text] [Related]
40. Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study.
Gidey K; Seifu M; Hailu BY; Asgedom SW; Niriayo YL
BMJ Open; 2020 Feb; 10(2):e034553. PubMed ID: 32102821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
